Author:
Proal Amy D.,Albert Paul J.,Marshall Trevor G.,Blaney Greg P.,Lindseth Inge A.
Publisher
Springer Science and Business Media LLC
Reference99 articles.
1. Komaroff AL, Cho TA. Role of infection and neurologic dysfunction in chronic fatigue syndrome. Semin Neurol. 2011;31(3):325–37.
2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953–9.
3. U.S. Food and Drug Administration. Drug development for myalgic encephalomyelitis and chronic fatigue syndrome (ME and CFS). 2012. http://www.fda.gov/downloads/Drugs/NewsEvents/UCM320310.pdf .
4. Fluge O, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS One. 2011;6(10):e26358. doi: 10.1371/journal.pone.0026358 .
5. Ortega-Hernandez OD, Shoenfeld Y. Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence? Ann N Y Acad Sci. 2009;1173:600–9. doi: 10.1111/j.1749-6632.2009.04799.x .
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献